0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dosage Control Syringe Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-11M17700
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dosage Control Syringe Market Research Report 2024
BUY CHAPTERS

Global Dosage Control Syringe Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11M17700
Report
October 2025
Pages:151
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dosage Control Syringe Market

The global Dosage Control Syringe market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Dosage Control Syringe leading manufacturers including B.Braun, Bayer, Merit Medical, Medline, MedNet, Comed, Argon Medical Devices, Edges Medicare, Advin Health Care, SCW Medicath, etc., dominate supply; the top five capture approximately % of global revenue, with B.Braun leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Dosage Control Syringe market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Dosage Control Syringe Market Report

Report Metric Details
Report Name Dosage Control Syringe Market
Segment by Type
  • 10ml
  • 12ml
  • 20ml
  • Others
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company B.Braun, Bayer, Merit Medical, Medline, MedNet, Comed, Argon Medical Devices, Edges Medicare, Advin Health Care, SCW Medicath, Shanghai INT Medical Instruments, Lepu Medical Technology, Jiangxi Hongda Medical Equipment Group, Shenzhen Antmed, BrosMed Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Dosage Control Syringe study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Dosage Control Syringe Market report?

Ans: The main players in the Dosage Control Syringe Market are B.Braun, Bayer, Merit Medical, Medline, MedNet, Comed, Argon Medical Devices, Edges Medicare, Advin Health Care, SCW Medicath, Shanghai INT Medical Instruments, Lepu Medical Technology, Jiangxi Hongda Medical Equipment Group, Shenzhen Antmed, BrosMed Medical

What are the Application segmentation covered in the Dosage Control Syringe Market report?

Ans: The Applications covered in the Dosage Control Syringe Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Dosage Control Syringe Market report?

Ans: The Types covered in the Dosage Control Syringe Market report are 10ml, 12ml, 20ml, Others

Recommended Reports

Syringe Product Markets

Disposable & Sterile Syringes

Drug Delivery Devices

1 Study Coverage
1.1 Introduction to Dosage Control Syringe: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dosage Control Syringe Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 10ml
1.2.3 12ml
1.2.4 20ml
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Dosage Control Syringe Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dosage Control Syringe Revenue Estimates and Forecasts 2020-2031
2.2 Global Dosage Control Syringe Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Dosage Control Syringe Sales Estimates and Forecasts 2020-2031
2.4 Global Dosage Control Syringe Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Dosage Control Syringe Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Dosage Control Syringe Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 10ml Market Size by Manufacturers
3.5.2 12ml Market Size by Manufacturers
3.5.3 20ml Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Dosage Control Syringe Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Dosage Control Syringe Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Dosage Control Syringe Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Dosage Control Syringe Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Dosage Control Syringe Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Dosage Control Syringe Sales and Revenue by Type (2020-2031)
6.4 North America Dosage Control Syringe Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Dosage Control Syringe Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Dosage Control Syringe Sales and Revenue by Type (2020-2031)
7.4 Europe Dosage Control Syringe Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Dosage Control Syringe Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Dosage Control Syringe Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Dosage Control Syringe Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Dosage Control Syringe Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Dosage Control Syringe Sales and Revenue by Type (2020-2031)
9.4 Central and South America Dosage Control Syringe Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Dosage Control Syringe Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Dosage Control Syringe Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Dosage Control Syringe Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Dosage Control Syringe Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 B.Braun
11.1.1 B.Braun Corporation Information
11.1.2 B.Braun Business Overview
11.1.3 B.Braun Dosage Control Syringe Product Models, Descriptions and Specifications
11.1.4 B.Braun Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 B.Braun Dosage Control Syringe Sales by Product in 2024
11.1.6 B.Braun Dosage Control Syringe Sales by Application in 2024
11.1.7 B.Braun Dosage Control Syringe Sales by Geographic Area in 2024
11.1.8 B.Braun Dosage Control Syringe SWOT Analysis
11.1.9 B.Braun Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Business Overview
11.2.3 Bayer Dosage Control Syringe Product Models, Descriptions and Specifications
11.2.4 Bayer Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Bayer Dosage Control Syringe Sales by Product in 2024
11.2.6 Bayer Dosage Control Syringe Sales by Application in 2024
11.2.7 Bayer Dosage Control Syringe Sales by Geographic Area in 2024
11.2.8 Bayer Dosage Control Syringe SWOT Analysis
11.2.9 Bayer Recent Developments
11.3 Merit Medical
11.3.1 Merit Medical Corporation Information
11.3.2 Merit Medical Business Overview
11.3.3 Merit Medical Dosage Control Syringe Product Models, Descriptions and Specifications
11.3.4 Merit Medical Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Merit Medical Dosage Control Syringe Sales by Product in 2024
11.3.6 Merit Medical Dosage Control Syringe Sales by Application in 2024
11.3.7 Merit Medical Dosage Control Syringe Sales by Geographic Area in 2024
11.3.8 Merit Medical Dosage Control Syringe SWOT Analysis
11.3.9 Merit Medical Recent Developments
11.4 Medline
11.4.1 Medline Corporation Information
11.4.2 Medline Business Overview
11.4.3 Medline Dosage Control Syringe Product Models, Descriptions and Specifications
11.4.4 Medline Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Medline Dosage Control Syringe Sales by Product in 2024
11.4.6 Medline Dosage Control Syringe Sales by Application in 2024
11.4.7 Medline Dosage Control Syringe Sales by Geographic Area in 2024
11.4.8 Medline Dosage Control Syringe SWOT Analysis
11.4.9 Medline Recent Developments
11.5 MedNet
11.5.1 MedNet Corporation Information
11.5.2 MedNet Business Overview
11.5.3 MedNet Dosage Control Syringe Product Models, Descriptions and Specifications
11.5.4 MedNet Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 MedNet Dosage Control Syringe Sales by Product in 2024
11.5.6 MedNet Dosage Control Syringe Sales by Application in 2024
11.5.7 MedNet Dosage Control Syringe Sales by Geographic Area in 2024
11.5.8 MedNet Dosage Control Syringe SWOT Analysis
11.5.9 MedNet Recent Developments
11.6 Comed
11.6.1 Comed Corporation Information
11.6.2 Comed Business Overview
11.6.3 Comed Dosage Control Syringe Product Models, Descriptions and Specifications
11.6.4 Comed Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Comed Recent Developments
11.7 Argon Medical Devices
11.7.1 Argon Medical Devices Corporation Information
11.7.2 Argon Medical Devices Business Overview
11.7.3 Argon Medical Devices Dosage Control Syringe Product Models, Descriptions and Specifications
11.7.4 Argon Medical Devices Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Argon Medical Devices Recent Developments
11.8 Edges Medicare
11.8.1 Edges Medicare Corporation Information
11.8.2 Edges Medicare Business Overview
11.8.3 Edges Medicare Dosage Control Syringe Product Models, Descriptions and Specifications
11.8.4 Edges Medicare Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Edges Medicare Recent Developments
11.9 Advin Health Care
11.9.1 Advin Health Care Corporation Information
11.9.2 Advin Health Care Business Overview
11.9.3 Advin Health Care Dosage Control Syringe Product Models, Descriptions and Specifications
11.9.4 Advin Health Care Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Advin Health Care Recent Developments
11.10 SCW Medicath
11.10.1 SCW Medicath Corporation Information
11.10.2 SCW Medicath Business Overview
11.10.3 SCW Medicath Dosage Control Syringe Product Models, Descriptions and Specifications
11.10.4 SCW Medicath Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 SCW Medicath Recent Developments
11.11 Shanghai INT Medical Instruments
11.11.1 Shanghai INT Medical Instruments Corporation Information
11.11.2 Shanghai INT Medical Instruments Business Overview
11.11.3 Shanghai INT Medical Instruments Dosage Control Syringe Product Models, Descriptions and Specifications
11.11.4 Shanghai INT Medical Instruments Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Shanghai INT Medical Instruments Recent Developments
11.12 Lepu Medical Technology
11.12.1 Lepu Medical Technology Corporation Information
11.12.2 Lepu Medical Technology Business Overview
11.12.3 Lepu Medical Technology Dosage Control Syringe Product Models, Descriptions and Specifications
11.12.4 Lepu Medical Technology Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Lepu Medical Technology Recent Developments
11.13 Jiangxi Hongda Medical Equipment Group
11.13.1 Jiangxi Hongda Medical Equipment Group Corporation Information
11.13.2 Jiangxi Hongda Medical Equipment Group Business Overview
11.13.3 Jiangxi Hongda Medical Equipment Group Dosage Control Syringe Product Models, Descriptions and Specifications
11.13.4 Jiangxi Hongda Medical Equipment Group Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Jiangxi Hongda Medical Equipment Group Recent Developments
11.14 Shenzhen Antmed
11.14.1 Shenzhen Antmed Corporation Information
11.14.2 Shenzhen Antmed Business Overview
11.14.3 Shenzhen Antmed Dosage Control Syringe Product Models, Descriptions and Specifications
11.14.4 Shenzhen Antmed Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Shenzhen Antmed Recent Developments
11.15 BrosMed Medical
11.15.1 BrosMed Medical Corporation Information
11.15.2 BrosMed Medical Business Overview
11.15.3 BrosMed Medical Dosage Control Syringe Product Models, Descriptions and Specifications
11.15.4 BrosMed Medical Dosage Control Syringe Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 BrosMed Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Dosage Control Syringe Industry Chain
12.2 Dosage Control Syringe Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Dosage Control Syringe Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Dosage Control Syringe Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Dosage Control Syringe Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Dosage Control Syringe Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Dosage Control Syringe Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Dosage Control Syringe Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Dosage Control Syringe Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Dosage Control Syringe Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Dosage Control Syringe Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Dosage Control Syringe Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M Units)
 Table 7. Global Dosage Control Syringe Sales by Region (2020-2025) & (M Units)
 Table 8. Global Dosage Control Syringe Sales by Region (2026-2031) & (M Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Dosage Control Syringe Sales by Manufacturers (2020-2025) & (M Units)
 Table 11. Global Dosage Control Syringe Sales Share by Manufacturers (2020-2025)
 Table 12. Global Dosage Control Syringe Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Dosage Control Syringe Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Dosage Control Syringe by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dosage Control Syringe as of 2024)
 Table 16. Global Dosage Control Syringe Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Dosage Control Syringe Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Dosage Control Syringe Manufacturing Base and Headquarters
 Table 19. Global Dosage Control Syringe Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Dosage Control Syringe Sales by Type (2020-2025) & (M Units)
 Table 23. Global Dosage Control Syringe Sales by Type (2026-2031) & (M Units)
 Table 24. Global Dosage Control Syringe Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Dosage Control Syringe Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Dosage Control Syringe ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Dosage Control Syringe Sales by Application (2020-2025) & (M Units)
 Table 29. Global Dosage Control Syringe Sales by Application (2026-2031) & (M Units)
 Table 30. Dosage Control Syringe High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Dosage Control Syringe Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Dosage Control Syringe Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Dosage Control Syringe ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Dosage Control Syringe Growth Accelerators and Market Barriers
 Table 37. North America Dosage Control Syringe Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Dosage Control Syringe Sales (M Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Dosage Control Syringe Growth Accelerators and Market Barriers
 Table 40. Europe Dosage Control Syringe Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Dosage Control Syringe Sales (M Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Dosage Control Syringe Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Dosage Control Syringe Sales (M Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Dosage Control Syringe Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Dosage Control Syringe Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Dosage Control Syringe Investment Opportunities and Key Challenges
 Table 47. Central and South America Dosage Control Syringe Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Dosage Control Syringe Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Dosage Control Syringe Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. B.Braun Corporation Information
 Table 51. B.Braun Description and Major Businesses
 Table 52. B.Braun Product Models, Descriptions and Specifications
 Table 53. B.Braun Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. B.Braun Sales Value Proportion by Product in 2024
 Table 55. B.Braun Sales Value Proportion by Application in 2024
 Table 56. B.Braun Sales Value Proportion by Geographic Area in 2024
 Table 57. B.Braun Dosage Control Syringe SWOT Analysis
 Table 58. B.Braun Recent Developments
 Table 59. Bayer Corporation Information
 Table 60. Bayer Description and Major Businesses
 Table 61. Bayer Product Models, Descriptions and Specifications
 Table 62. Bayer Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Bayer Sales Value Proportion by Product in 2024
 Table 64. Bayer Sales Value Proportion by Application in 2024
 Table 65. Bayer Sales Value Proportion by Geographic Area in 2024
 Table 66. Bayer Dosage Control Syringe SWOT Analysis
 Table 67. Bayer Recent Developments
 Table 68. Merit Medical Corporation Information
 Table 69. Merit Medical Description and Major Businesses
 Table 70. Merit Medical Product Models, Descriptions and Specifications
 Table 71. Merit Medical Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Merit Medical Sales Value Proportion by Product in 2024
 Table 73. Merit Medical Sales Value Proportion by Application in 2024
 Table 74. Merit Medical Sales Value Proportion by Geographic Area in 2024
 Table 75. Merit Medical Dosage Control Syringe SWOT Analysis
 Table 76. Merit Medical Recent Developments
 Table 77. Medline Corporation Information
 Table 78. Medline Description and Major Businesses
 Table 79. Medline Product Models, Descriptions and Specifications
 Table 80. Medline Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Medline Sales Value Proportion by Product in 2024
 Table 82. Medline Sales Value Proportion by Application in 2024
 Table 83. Medline Sales Value Proportion by Geographic Area in 2024
 Table 84. Medline Dosage Control Syringe SWOT Analysis
 Table 85. Medline Recent Developments
 Table 86. MedNet Corporation Information
 Table 87. MedNet Description and Major Businesses
 Table 88. MedNet Product Models, Descriptions and Specifications
 Table 89. MedNet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. MedNet Sales Value Proportion by Product in 2024
 Table 91. MedNet Sales Value Proportion by Application in 2024
 Table 92. MedNet Sales Value Proportion by Geographic Area in 2024
 Table 93. MedNet Dosage Control Syringe SWOT Analysis
 Table 94. MedNet Recent Developments
 Table 95. Comed Corporation Information
 Table 96. Comed Description and Major Businesses
 Table 97. Comed Product Models, Descriptions and Specifications
 Table 98. Comed Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Comed Recent Developments
 Table 100. Argon Medical Devices Corporation Information
 Table 101. Argon Medical Devices Description and Major Businesses
 Table 102. Argon Medical Devices Product Models, Descriptions and Specifications
 Table 103. Argon Medical Devices Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Argon Medical Devices Recent Developments
 Table 105. Edges Medicare Corporation Information
 Table 106. Edges Medicare Description and Major Businesses
 Table 107. Edges Medicare Product Models, Descriptions and Specifications
 Table 108. Edges Medicare Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Edges Medicare Recent Developments
 Table 110. Advin Health Care Corporation Information
 Table 111. Advin Health Care Description and Major Businesses
 Table 112. Advin Health Care Product Models, Descriptions and Specifications
 Table 113. Advin Health Care Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Advin Health Care Recent Developments
 Table 115. SCW Medicath Corporation Information
 Table 116. SCW Medicath Description and Major Businesses
 Table 117. SCW Medicath Product Models, Descriptions and Specifications
 Table 118. SCW Medicath Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. SCW Medicath Recent Developments
 Table 120. Shanghai INT Medical Instruments Corporation Information
 Table 121. Shanghai INT Medical Instruments Description and Major Businesses
 Table 122. Shanghai INT Medical Instruments Product Models, Descriptions and Specifications
 Table 123. Shanghai INT Medical Instruments Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Shanghai INT Medical Instruments Recent Developments
 Table 125. Lepu Medical Technology Corporation Information
 Table 126. Lepu Medical Technology Description and Major Businesses
 Table 127. Lepu Medical Technology Product Models, Descriptions and Specifications
 Table 128. Lepu Medical Technology Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Lepu Medical Technology Recent Developments
 Table 130. Jiangxi Hongda Medical Equipment Group Corporation Information
 Table 131. Jiangxi Hongda Medical Equipment Group Description and Major Businesses
 Table 132. Jiangxi Hongda Medical Equipment Group Product Models, Descriptions and Specifications
 Table 133. Jiangxi Hongda Medical Equipment Group Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Jiangxi Hongda Medical Equipment Group Recent Developments
 Table 135. Shenzhen Antmed Corporation Information
 Table 136. Shenzhen Antmed Description and Major Businesses
 Table 137. Shenzhen Antmed Product Models, Descriptions and Specifications
 Table 138. Shenzhen Antmed Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Shenzhen Antmed Recent Developments
 Table 140. BrosMed Medical Corporation Information
 Table 141. BrosMed Medical Description and Major Businesses
 Table 142. BrosMed Medical Product Models, Descriptions and Specifications
 Table 143. BrosMed Medical Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. BrosMed Medical Recent Developments
 Table 145. Key Raw Materials Distribution
 Table 146. Raw Materials Key Suppliers
 Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 148. Milestones in Production Technology Evolution
 Table 149. Distributors List
 Table 150. Market Trends and Market Evolution
 Table 151. Market Drivers and Opportunities
 Table 152. Market Challenges, Risks, and Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources


List of Figures
 Figure 1. Dosage Control Syringe Product Picture
 Figure 2. Global Dosage Control Syringe Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 10ml Product Picture
 Figure 4. 12ml Product Picture
 Figure 5. 20ml Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Dosage Control Syringe Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Dosage Control Syringe Report Years Considered
 Figure 12. Global Dosage Control Syringe Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Dosage Control Syringe Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Dosage Control Syringe Revenue Market Share by Region (2020-2031)
 Figure 16. Global Dosage Control Syringe Sales (2020-2031) & (M Units)
 Figure 17. Global Dosage Control Syringe Sales (CAGR) by Region (2020-2031) (M Units)
 Figure 18. Global Dosage Control Syringe Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Dosage Control Syringe Sales Volume Market Share in 2024
 Figure 20. Global Dosage Control Syringe Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. 10ml Revenue Market Share by Manufacturer in 2024
 Figure 23. 12ml Revenue Market Share by Manufacturer in 2024
 Figure 24. 20ml Revenue Market Share by Manufacturer in 2024
 Figure 25. Others Revenue Market Share by Manufacturer in 2024
 Figure 26. Global Dosage Control Syringe Sales Market Share by Type (2020-2031)
 Figure 27. Global Dosage Control Syringe Revenue Market Share by Type (2020-2031)
 Figure 28. Global Dosage Control Syringe Sales Market Share by Application (2020-2031)
 Figure 29. Global Dosage Control Syringe Revenue Market Share by Application (2020-2031)
 Figure 30. North America Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
 Figure 31. North America Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
 Figure 33. North America Dosage Control Syringe Sales Volume (M Units) by Type (2020- 2031)
 Figure 34. North America Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 35. North America Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
 Figure 36. North America Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
 Figure 41. Europe Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
 Figure 43. Europe Dosage Control Syringe Sales Volume (M Units) by Type (2020-2031)
 Figure 44. Europe Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Europe Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
 Figure 46. Europe Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 48. France Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
 Figure 53. Asia-Pacific Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific Dosage Control Syringe Sales Volume (M Units) by Type (2020- 2031)
 Figure 56. Asia-Pacific Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 57. Asia-Pacific Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
 Figure 58. Asia-Pacific Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 63. India Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
 Figure 65. Central and South America Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America Dosage Control Syringe Sales Volume (M Units) by Type (2021-2031)
 Figure 68. Central and South America Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 69. Central and South America Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
 Figure 70. Central and South America Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
 Figure 74. Middle East and Africa Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa Dosage Control Syringe Sales Volume (M Units) by Type (2021-2031)
 Figure 77. South America Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Middle East and Africa Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
 Figure 79. Middle East and Africa Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
 Figure 84. Dosage Control Syringe Industry Chain Mapping
 Figure 85. Regional Dosage Control Syringe Manufacturing Base Distribution (%)
 Figure 86. Global Dosage Control Syringe Production Market Share by Region (2020-2031)
 Figure 87. Dosage Control Syringe Production Process
 Figure 88. Regional Dosage Control Syringe Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart